Literature DB >> 19381840

Population-based mechanistic prediction of oral drug absorption.

Masoud Jamei1, David Turner, Jiansong Yang, Sibylle Neuhoff, Sebastian Polak, Amin Rostami-Hodjegan, Geoffrey Tucker.   

Abstract

The bioavailability of drugs from oral formulations is influenced by many physiological factors including gastrointestinal fluid composition, pH and dynamics, transit and motility, and metabolism and transport, each of which may vary with age, gender, race, food, and disease. Therefore, oral bioavailability, particularly of poorly soluble and/or poorly permeable compounds and those that are extensively metabolized, often exhibits a high degree of inter- and intra-individual variability. While several models and algorithms have been developed to predict bioavailability in an average person, efforts to accommodate intrinsic variability in the component processes are less common. An approach that incorporates such variability for human populations within a mechanistic framework is described together with examples of its application to drug and formulation development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19381840      PMCID: PMC2691459          DOI: 10.1208/s12248-009-9099-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  117 in total

1.  The Gibbs constant and pH solubility profiles.

Authors:  W H Streng
Journal:  Int J Pharm       Date:  1999-09-20       Impact factor: 5.875

2.  General solution for diffusion-controlled dissolution of spherical particles. 1. Theory.

Authors:  J Wang; D R Flanagan
Journal:  J Pharm Sci       Date:  1999-07       Impact factor: 3.534

3.  A formula to estimate the approximate surface area if height and weight be known. 1916.

Authors:  D Du Bois; E F Du Bois
Journal:  Nutrition       Date:  1989 Sep-Oct       Impact factor: 4.008

Review 4.  Magnetic Marker Monitoring: An application of biomagnetic measurement instrumentation and principles for the determination of the gastrointestinal behavior of magnetically marked solid dosage forms.

Authors:  Werner Weitschies; Olaf Kosch; Hubert Mönnikes; Lutz Trahms
Journal:  Adv Drug Deliv Rev       Date:  2005-04-08       Impact factor: 15.470

Review 5.  Microenvironmental pH modulation in solid dosage forms.

Authors:  Sherif I Farag Badawy; Munir A Hussain
Journal:  J Pharm Sci       Date:  2007-05       Impact factor: 3.534

Review 6.  Metabolism of drugs and other xenobiotics in the gut lumen and wall.

Authors:  K F Ilett; L B Tee; P T Reeves; R F Minchin
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

7.  Drug dissolution into micellar solutions: development of a convective diffusion model and comparison to the film equilibrium model with application to surfactant-facilitated dissolution of carbamazepine.

Authors:  J R Crison; V P Shah; J P Skelly; G L Amidon
Journal:  J Pharm Sci       Date:  1996-09       Impact factor: 3.534

8.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

9.  Upper gastrointestinal (GI) pH in young, healthy men and women.

Authors:  J B Dressman; R R Berardi; L C Dermentzoglou; T L Russell; S P Schmaltz; J L Barnett; K M Jarvenpaa
Journal:  Pharm Res       Date:  1990-07       Impact factor: 4.200

10.  Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

Authors:  G Lake-Bakaar; W Tom; D Lake-Bakaar; N Gupta; S Beidas; M Elsakr; E Straus
Journal:  Ann Intern Med       Date:  1988-09-15       Impact factor: 25.391

View more
  97 in total

1.  Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs.

Authors:  M N Martinez; B Mistry; V Lukacova; K A Lentz; J E Polli; S W Hoag; T Dowling; R Kona; R M Fahmy
Journal:  AAPS J       Date:  2017-03-06       Impact factor: 4.009

Review 2.  Trends in oral drug bioavailability following bariatric surgery: examining the variable extent of impact on exposure of different drug classes.

Authors:  Adam S Darwich; Kathryn Henderson; Angela Burgin; Nicola Ward; Janet Whittam; Basil J Ammori; Darren M Ashcroft; Amin Rostami-Hodjegan
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

3.  A semi-mechanistic modeling strategy to link in vitro and in vivo drug release for modified release formulations.

Authors:  Martin Bergstrand; Erik Söderlind; Ulf G Eriksson; Werner Weitschies; Mats O Karlsson
Journal:  Pharm Res       Date:  2011-09-27       Impact factor: 4.200

4.  Comparison of Deconvolution-Based and Absorption Modeling IVIVC for Extended Release Formulations of a BCS III Drug Development Candidate.

Authors:  Filippos Kesisoglou; Binfeng Xia; Nancy G B Agrawal
Journal:  AAPS J       Date:  2015-08-20       Impact factor: 4.009

Review 5.  Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.

Authors:  Jennifer E Sager; Jingjing Yu; Isabelle Ragueneau-Majlessi; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2015-08-21       Impact factor: 3.922

6.  Comment on: "A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood".

Authors:  Guo-Fu Li; Xiao Gu; Guo Yu; Shui-Yu Zhao; Qing-Shan Zheng
Journal:  Clin Pharmacokinet       Date:  2016-01       Impact factor: 6.447

7.  Evaluating a physiologically based pharmacokinetic model for predicting the pharmacokinetics of midazolam in Chinese after oral administration.

Authors:  Hong-yun Wang; Xia Chen; Ji Jiang; Jun Shi; Pei Hu
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

8.  Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

Authors:  Swati Nagar; Richard C Korzekwa; Ken Korzekwa
Journal:  Mol Pharm       Date:  2017-07-31       Impact factor: 4.939

9.  Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin.

Authors:  Nikunjkumar Patel; Oliver Hatley; Alexander Berg; Klaus Romero; Barbara Wisniowska; Debra Hanna; David Hermann; Sebastian Polak
Journal:  AAPS J       Date:  2018-03-14       Impact factor: 4.009

Review 10.  ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans.

Authors:  M J Zamek-Gliszczynski; C A Lee; A Poirier; J Bentz; X Chu; H Ellens; T Ishikawa; M Jamei; J C Kalvass; S Nagar; K S Pang; K Korzekwa; P W Swaan; M E Taub; P Zhao; A Galetin
Journal:  Clin Pharmacol Ther       Date:  2013-02-25       Impact factor: 6.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.